{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Novel Drug Approvals (2015 - 2024)\n",
    "\n",
    "> **Goal:** This notebook will look at New Molecular Entities (NMEs) approved by the FDA. <br>\n",
    "> **Notebook Owner(s):** Time Bioventures <br>\n",
    "> **Date:** June 2024 <br>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "***\n",
    "## Import Libraries\n",
    "\n",
    "Import the libraries you will be using throughout the project."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "import time\n",
    "import datetime\n",
    "import requests\n",
    "import pandas as pd\n",
    "from bs4 import BeautifulSoup\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "***\n",
    "## Scrape NME Tables\n",
    "\n",
    "Utilize [BeautifulSoup](https://beautiful-soup-4.readthedocs.io/en/latest/) to scrape all the NME tables (example: [2024 NMEs](https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024)) row-by-row, making sure you also capture the links for additional drug information."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Scraping drugs for year 2015...\n",
      "  Number of rows: 46\n",
      "Scraping drugs for year 2016...\n",
      "  Number of rows: 23\n",
      "Scraping drugs for year 2017...\n",
      "  Number of rows: 47\n",
      "Scraping drugs for year 2018...\n",
      "  Number of rows: 60\n",
      "Scraping drugs for year 2019...\n",
      "  Number of rows: 49\n",
      "Scraping drugs for year 2020...\n",
      "  Number of rows: 55\n",
      "Scraping drugs for year 2021...\n",
      "  Number of rows: 51\n",
      "Scraping drugs for year 2022...\n",
      "  Number of rows: 38\n",
      "Scraping drugs for year 2023...\n",
      "  Number of rows: 56\n",
      "Scraping drugs for year 2024...\n",
      "  Number of rows: 17\n",
      "Number of recent drugs: 429\n",
      "Scraping archived drugs from http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm483775.htm...\n",
      "  Number of rows: 19\n",
      "Scraping archived drugs from http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm430302.htm...\n",
      "  Number of rows: 46\n",
      "Scraping archived drugs from http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm429247.htm...\n",
      "  Number of rows: 42\n",
      "Scraping archived drugs from http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm381263.htm...\n",
      "  Number of rows: 29\n",
      "Scraping archived drugs from http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm336115.htm...\n",
      "  Number of rows: 40\n",
      "Scraping archived drugs from http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm285554.htm...\n",
      "  Number of rows: 30\n",
      "Number of archived drugs: 170\n",
      "Cleaning dataframe...\n",
      " Number of rows before cleaning: 599\n",
      " Number of rows after cleaning: 537\n"
     ]
    }
   ],
   "source": [
    "def initialize_df():\n",
    "\tdf = pd.DataFrame({\n",
    "\t\t\"year\": [],\n",
    "\t\t\"year_approval_count\": [],\n",
    "\t\t\"drug_name\": [],\n",
    "\t\t\"active_ingredient\": [],\n",
    "\t\t\"approval_date\": [],\n",
    "\t\t\"approved_use\": [],\n",
    "\t\t\"drug_link\": [],\n",
    "\t\t\"press_release\": [],\n",
    "\t\t\"drug_trials_snapshot\": []\n",
    "\t})\n",
    "\treturn df\n",
    "\n",
    "def scrape_drug_cols(cols):\n",
    "\tdrug_dict = {\n",
    "\t\t\"drug_name\": None,\n",
    "\t\t\"active_ingredient\": None,\n",
    "\t\t\"approval_date\": None,\n",
    "\t\t\"approved_use\": None,\n",
    "\t\t\"drug_link\": None,\n",
    "\t\t\"press_release\": None,\n",
    "\t\t\"drug_trials_snapshot\": None\n",
    "\t}\n",
    "\n",
    "\tbase_link = \"https://www.fda.gov\"\n",
    "\n",
    "\t# some rows have only active-ingredient (i.e. asuvimab-zykl) and no other info\n",
    "\tif len(cols) < 5 or cols[0].get_text().strip() == \"*\":\n",
    "\t\treturn drug_dict\n",
    "\t# most drugs have 5 columns\n",
    "\tif len(cols) == 5:\n",
    "\t\tyear_index, drug_name_index, active_ingredient_index, approval_date_index, approved_use_index = 0, 1, 2, 3, 4\n",
    "\telse:\n",
    "\t\tyear_index, drug_name_index, active_ingredient_index, approval_date_index, approved_use_index = 0, 1, 2, 4, 5\n",
    "\t# year drug count\n",
    "\tdrug_dict['year_index'] = cols[year_index].get_text().strip().replace('.', '')\n",
    "\t# drug name\n",
    "\tdrug_dict['drug_name'] = cols[drug_name_index].get_text().strip()\n",
    "\t# drug link (if available)\n",
    "\tif len(cols[drug_name_index].find_all(\"a\")) > 0:\n",
    "\t\tdrug_dict['drug_link'] = cols[drug_name_index].find(\"a\")[\"href\"].strip()\n",
    "\t# active ingredient\n",
    "\tdrug_dict['active_ingredient'] = cols[active_ingredient_index].get_text().strip()\n",
    "\t# for only one drug, the drug_link is in the active ingredient \n",
    "\tif len(cols[active_ingredient_index].find_all(\"a\")) > 0:\n",
    "\t\tdrug_link = cols[active_ingredient_index].find(\"a\")[\"href\"].strip()\n",
    "\t# approval date\n",
    "\tapproval_date = cols[approval_date_index].get_text().strip()\n",
    "\t# see if the date is in m/d/Y or m/d/y format\n",
    "\tif len(approval_date.split(\"/\")[2]) == 4:\n",
    "\t\t# convert d/m/y to YYYY-MM-DD format\n",
    "\t\tdrug_dict['approval_date'] = datetime.datetime.strptime(approval_date, \"%m/%d/%Y\").strftime(\"%Y-%m-%d\")\n",
    "\telif len(approval_date.split(\"/\")[2]) == 2:\n",
    "\t\tdrug_dict['approval_date'] = datetime.datetime.strptime(approval_date, \"%m/%d/%y\").strftime(\"%Y-%m-%d\")\n",
    "\t# FDA made a mistake on Firdapse approval date stating 2028 instead of 2018 and Jardiance approval date stating 2104 instead of 2014\n",
    "\tif drug_dict['drug_name'] == \"Firdapse\":\n",
    "\t\tdrug_dict['approval_date'] = drug_dict['approval_date'].replace(\"2028\", \"2018\")\n",
    "\tif drug_dict['drug_name'] == \"Jardiance\":\n",
    "\t\tdrug_dict['approval_date'] = drug_dict['approval_date'].replace(\"2104\", \"2014\")\n",
    "\t# approved use\n",
    "\tdrug_dict['approved_use'] = cols[approved_use_index].get_text().strip()\n",
    "\t# approved use links\n",
    "\tapproved_use_links = cols[approved_use_index].find_all(\"a\")\n",
    "\t# get hrefs for approved use links\n",
    "\tapproved_use_hrefs = [a[\"href\"] for a in approved_use_links]\n",
    "\tdrug_dict['press_release'] = None\n",
    "\tdrug_dict['drug_trials_snapshot'] = None\n",
    "\tfor i, link in enumerate(approved_use_hrefs):\n",
    "\t\tif 'news-events' in link:\n",
    "\t\t\t# few of the links sporadically have the base_link already \n",
    "\t\t\tdrug_dict['press_release'] = base_link + link.replace('base_link', '')\n",
    "\t\telif 'drug-trials' in link:\n",
    "\t\t\tdrug_dict['drug_trials_snapshot'] = base_link + link.replace('base_link', '')\n",
    "\treturn drug_dict\n",
    "\n",
    "def scrape_fda_nce(year, url, df_all):\n",
    "\tresponse = requests.get(url)\n",
    "\tsoup = BeautifulSoup(response.text, \"html.parser\")\n",
    "\tdf_year = initialize_df()\n",
    "\tif year is None:\n",
    "\t\t# get year from the h1 tag\n",
    "\t\tyear = str(int(soup.find_all(\"h1\")[0].get_text().split(\" \")[-1]))\n",
    "\t# scraping table and converting to dataframe had errors due to extra rows in some drug entries\n",
    "\ttable = soup.find_all(\"table\")[0]\n",
    "\t# iterate through each row in the table and get the text and link(s) for each drug\n",
    "\trows = table.find_all(\"tr\")\n",
    "\tprint(f'  Number of rows: {len(rows)}')\n",
    "\tfor rix, row in enumerate(rows):\n",
    "\t\tdrug_dict = scrape_drug_cols(row.find_all(\"td\"))\n",
    "\t\tif url == 'http://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm285554.htm':\n",
    "\t\t\tcontinue\n",
    "\t\tif not drug_dict[\"drug_name\"]:\n",
    "\t\t\tcontinue\n",
    "\t\tdf = pd.DataFrame({\n",
    "\t\t\t\"year\": [year],\n",
    "\t\t\t\"year_approval_count\": drug_dict['year_index'],\n",
    "\t\t\t\"drug_name\": drug_dict['drug_name'],\n",
    "\t\t\t\"active_ingredient\": drug_dict['active_ingredient'],\n",
    "\t\t\t\"approval_date\": drug_dict['approval_date'],\n",
    "\t\t\t\"approved_use\": drug_dict['approved_use'],\n",
    "\t\t\t\"drug_link\": drug_dict['drug_link'],\n",
    "\t\t\t\"press_release\": drug_dict['press_release'],\n",
    "\t\t\t\"drug_trials_snapshot\": drug_dict['drug_trials_snapshot']\n",
    "\t\t})\n",
    "\t\tdf_year = pd.concat([df_year, df], ignore_index=True)\n",
    "\treturn df_year\n",
    "\n",
    "def scrape_recent_drugs():\n",
    "\t# get currrent year\n",
    "\tcurr_year = datetime.datetime.now().year\n",
    "\tdf_recent = pd.DataFrame()\n",
    "\tfor year in range(2015, curr_year+1):\n",
    "\t\tprint(f'Scraping drugs for year {year}...')\n",
    "\t\turl = f\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-{year}\"\n",
    "\t\tdf = scrape_fda_nce(str(int(year)), url, df_all)\n",
    "\t\tdf_recent = pd.concat([df_recent, df], ignore_index=True)\n",
    "\treturn df_recent\n",
    "\n",
    "def scrape_archived_drugs():\n",
    "\tbase_link = 'http://wayback.archive-it.org'\n",
    "\turl = \"https://wayback.archive-it.org/7993/20161022052127/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm483775.htm\"\n",
    "\tdf_archived = pd.DataFrame()\n",
    "\tresponse = requests.get(url)\n",
    "\tsoup = BeautifulSoup(response.text, \"html.parser\")\n",
    "\t# find all links\n",
    "\tlinks = soup.find_all(\"a\")\n",
    "\t# get all links with \"Novel Drug Approvals for\" in the text\n",
    "\tlinks = [link for link in links if \"Novel Drug Approvals for\" in link.get_text()]\n",
    "\t# get the hrefs for the links\n",
    "\tlinks = [base_link + link[\"href\"] for link in links]\n",
    "\tfor link in links:\n",
    "\t\tprint(f'Scraping archived drugs from {link}...')\n",
    "\t\tdf = scrape_fda_nce(None, link, df_archived)\n",
    "\t\tif df['drug_name'].isnull().all():\n",
    "\t\t\tcontinue\n",
    "\t\tdf_archived = pd.concat([df_archived, df], ignore_index=True)\n",
    "\treturn df_archived\n",
    "\n",
    "def clean_df(df):\n",
    "\tprint('Cleaning dataframe...')\n",
    "\tprint(f' Number of rows before cleaning: {len(df)}')\n",
    "\t# convert year to int\n",
    "\tdf['year'] = df['year'].astype(int)\n",
    "\t# convert year_approval_count to int and remove punctuation\n",
    "\tdf['year_approval_count'] = df['year_approval_count'].str.replace(',', '').astype(int)\n",
    "\t# remove any duplicate rows with the same active_ingredient \n",
    "\tdf = df.drop_duplicates(subset=['active_ingredient'], keep='first')\n",
    "\t# sort by year and drug name\n",
    "\tdf = df.sort_values(by=['year', 'year_approval_count'])\n",
    "\t# reset index\n",
    "\tdf = df.reset_index(drop=True)\n",
    "\tprint(f' Number of rows after cleaning: {len(df)}')\n",
    "\treturn df\n",
    "\n",
    "def scrape_nce():\n",
    "\tdf_recent = scrape_recent_drugs()\n",
    "\tprint('Number of recent drugs:', len(df_recent))\n",
    "\tdf_archived = scrape_archived_drugs()\n",
    "\tprint('Number of archived drugs:', len(df_archived))\n",
    "\tdf_all = pd.concat([df_recent, df_archived], ignore_index=True)\n",
    "\tdf_all = clean_df(df_all)\n",
    "\treturn df_all\n",
    "\n",
    "df_all = scrape_nce()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>year</th>\n",
       "      <th>year_approval_count</th>\n",
       "      <th>drug_name</th>\n",
       "      <th>active_ingredient</th>\n",
       "      <th>approval_date</th>\n",
       "      <th>approved_use</th>\n",
       "      <th>drug_link</th>\n",
       "      <th>press_release</th>\n",
       "      <th>drug_trials_snapshot</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2012</td>\n",
       "      <td>1</td>\n",
       "      <td>Voraxaze</td>\n",
       "      <td>glucarpidase</td>\n",
       "      <td>2012-01-17</td>\n",
       "      <td>To treat patients with toxic levels of methotrexate in their blood due to kidney failure. Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=125327&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2012</td>\n",
       "      <td>2</td>\n",
       "      <td>Picato</td>\n",
       "      <td>ingenol mebutate</td>\n",
       "      <td>2012-01-23</td>\n",
       "      <td>For the topical treatment of actinic keratosis.</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=202833&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2012</td>\n",
       "      <td>3</td>\n",
       "      <td>Inlyta</td>\n",
       "      <td>axitinib</td>\n",
       "      <td>2012-01-27</td>\n",
       "      <td>To treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=202324&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2012</td>\n",
       "      <td>4</td>\n",
       "      <td>Erivedge</td>\n",
       "      <td>vismodegib</td>\n",
       "      <td>2012-01-30</td>\n",
       "      <td>To treat adult patients with basal cell carcinoma, the most common type of skin cancer.Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=203388&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2012</td>\n",
       "      <td>5</td>\n",
       "      <td>Kalydeco</td>\n",
       "      <td>ivacaftor</td>\n",
       "      <td>2012-01-31</td>\n",
       "      <td>For the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene. Press Release</td>\n",
       "      <td></td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2012</td>\n",
       "      <td>6</td>\n",
       "      <td>Zioptan</td>\n",
       "      <td>tafluprost</td>\n",
       "      <td>2012-02-10</td>\n",
       "      <td>For reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=202514&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>2012</td>\n",
       "      <td>7</td>\n",
       "      <td>Surfaxin</td>\n",
       "      <td>lucinactant</td>\n",
       "      <td>2012-03-06</td>\n",
       "      <td>For the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=021746&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>2012</td>\n",
       "      <td>8</td>\n",
       "      <td>Omontys</td>\n",
       "      <td>peginesatide</td>\n",
       "      <td>2012-03-27</td>\n",
       "      <td>To treat anemia, a condition in which the body does not have enough healthy red blood cells, in adult dialysis patients who have chronic kidney disease (CKD).Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=202799&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>2012</td>\n",
       "      <td>9</td>\n",
       "      <td>Amyvid</td>\n",
       "      <td>Florbetapir F 18</td>\n",
       "      <td>2012-04-06</td>\n",
       "      <td>Used as a radioactive diagnostic agent for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=202008&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>2012</td>\n",
       "      <td>10</td>\n",
       "      <td>Stendra</td>\n",
       "      <td>avanafil</td>\n",
       "      <td>2012-04-27</td>\n",
       "      <td>To treat erectile dysfunction.Press Release</td>\n",
       "      <td>http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;searchTerm=202276&amp;SearchType=BasicSearch</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   year  year_approval_count drug_name active_ingredient approval_date  \\\n",
       "0  2012                    1  Voraxaze      glucarpidase    2012-01-17   \n",
       "1  2012                    2    Picato  ingenol mebutate    2012-01-23   \n",
       "2  2012                    3    Inlyta          axitinib    2012-01-27   \n",
       "3  2012                    4  Erivedge        vismodegib    2012-01-30   \n",
       "4  2012                    5  Kalydeco         ivacaftor    2012-01-31   \n",
       "5  2012                    6   Zioptan        tafluprost    2012-02-10   \n",
       "6  2012                    7  Surfaxin       lucinactant    2012-03-06   \n",
       "7  2012                    8   Omontys      peginesatide    2012-03-27   \n",
       "8  2012                    9    Amyvid  Florbetapir F 18    2012-04-06   \n",
       "9  2012                   10   Stendra          avanafil    2012-04-27   \n",
       "\n",
       "                                                                                                                                                                                                                                                                               approved_use  \\\n",
       "0                                                                                                                                                                                   To treat patients with toxic levels of methotrexate in their blood due to kidney failure. Press Release   \n",
       "1                                                                                                                                                                                                                                           For the topical treatment of actinic keratosis.   \n",
       "2                                                                                                                                         To treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.Press Release   \n",
       "3                                                                                                                                                                                      To treat adult patients with basal cell carcinoma, the most common type of skin cancer.Press Release   \n",
       "4                                                                                For the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene. Press Release   \n",
       "5                                                                                                                                                                      For reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.Press Release   \n",
       "6                                                                                                                                                              For the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.Press Release   \n",
       "7                                                                                                               To treat anemia, a condition in which the body does not have enough healthy red blood cells, in adult dialysis patients who have chronic kidney disease (CKD).Press Release   \n",
       "8  Used as a radioactive diagnostic agent for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.   \n",
       "9                                                                                                                                                                                                                                               To treat erectile dysfunction.Press Release   \n",
       "\n",
       "                                                                                                                                                                                   drug_link  \\\n",
       "0  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=125327&SearchType=BasicSearch   \n",
       "1  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=202833&SearchType=BasicSearch   \n",
       "2  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=202324&SearchType=BasicSearch   \n",
       "3  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=203388&SearchType=BasicSearch   \n",
       "4                                                                                                                                                                                              \n",
       "5  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=202514&SearchType=BasicSearch   \n",
       "6  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=021746&SearchType=BasicSearch   \n",
       "7  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=202799&SearchType=BasicSearch   \n",
       "8  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=202008&SearchType=BasicSearch   \n",
       "9  http://wayback.archive-it.org/7993/20161022052138/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&searchTerm=202276&SearchType=BasicSearch   \n",
       "\n",
       "  press_release drug_trials_snapshot  \n",
       "0          None                 None  \n",
       "1          None                 None  \n",
       "2          None                 None  \n",
       "3          None                 None  \n",
       "4          None                 None  \n",
       "5          None                 None  \n",
       "6          None                 None  \n",
       "7          None                 None  \n",
       "8          None                 None  \n",
       "9          None                 None  "
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_all.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "***\n",
    "## View Output Table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>year</th>\n",
       "      <th>year_approval_count</th>\n",
       "      <th>drug_name</th>\n",
       "      <th>active_ingredient</th>\n",
       "      <th>approval_date</th>\n",
       "      <th>approved_use</th>\n",
       "      <th>drug_link</th>\n",
       "      <th>press_release</th>\n",
       "      <th>drug_trials_snapshot</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>517</th>\n",
       "      <td>2023</td>\n",
       "      <td>52</td>\n",
       "      <td>Ogsiveo</td>\n",
       "      <td>nirogacestat</td>\n",
       "      <td>2023-11-27</td>\n",
       "      <td>To treat adults with progressing desmoid tumors who require systemic treatmentDrug Trials Snapshot</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217677s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ogsiveo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>518</th>\n",
       "      <td>2023</td>\n",
       "      <td>53</td>\n",
       "      <td>Fabhalta</td>\n",
       "      <td>iptacopan</td>\n",
       "      <td>2023-12-05</td>\n",
       "      <td>To treat paroxysmal nocturnal hemoglobinuria</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/218276s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>519</th>\n",
       "      <td>2023</td>\n",
       "      <td>54</td>\n",
       "      <td>Filsuvez</td>\n",
       "      <td>birch triterpenes</td>\n",
       "      <td>2023-12-18</td>\n",
       "      <td>To treat wounds associated with dystrophic and junctional epidermolysis bullosaDrug Trials Snapshot</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215064s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-filsuvez</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>2023</td>\n",
       "      <td>55</td>\n",
       "      <td>Wainua</td>\n",
       "      <td>eplontersen</td>\n",
       "      <td>2023-12-21</td>\n",
       "      <td>To treat polyneuropathy of hereditary transthyretin-mediated amyloidosisDrug Trials Snapshot</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217388s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-wainua</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>521</th>\n",
       "      <td>2024</td>\n",
       "      <td>1</td>\n",
       "      <td>Zelsuvmi</td>\n",
       "      <td>berdazimer</td>\n",
       "      <td>2024-01-05</td>\n",
       "      <td>To treat molluscum contagiosumDrug Trials Snapshot</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217424s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-zelsuvmi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>522</th>\n",
       "      <td>2024</td>\n",
       "      <td>2</td>\n",
       "      <td>Exblifep</td>\n",
       "      <td>cefepime, enmetazobactam</td>\n",
       "      <td>2024-02-22</td>\n",
       "      <td>To treat complicated urinary tract infections</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216165s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>2024</td>\n",
       "      <td>3</td>\n",
       "      <td>Letybo</td>\n",
       "      <td>letibotulinumtoxinA-wlbg</td>\n",
       "      <td>2024-02-29</td>\n",
       "      <td>To temporarily improve the appearance of moderate-to-severe glabellar linesDrug Trials Snapshot</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761225s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-letybo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>524</th>\n",
       "      <td>2024</td>\n",
       "      <td>4</td>\n",
       "      <td>Tevimbra</td>\n",
       "      <td>tislelizumab-jsgr</td>\n",
       "      <td>2024-03-13</td>\n",
       "      <td>To treat unresectable or metastatic esophageal squamous cell carcinomaDrug Trials Snapshot</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761232Orig1s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-tevimbra</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>525</th>\n",
       "      <td>2024</td>\n",
       "      <td>5</td>\n",
       "      <td>Rezdiffra</td>\n",
       "      <td>resmetirom</td>\n",
       "      <td>2024-03-14</td>\n",
       "      <td>To treat noncirrhotic non-alcoholic steatohepatitis with moderate to advanced liver scarringPress Release</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217785s000lbl.pdf</td>\n",
       "      <td>https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>526</th>\n",
       "      <td>2024</td>\n",
       "      <td>6</td>\n",
       "      <td>Tryvio</td>\n",
       "      <td>aprocitentan</td>\n",
       "      <td>2024-03-19</td>\n",
       "      <td>To treat hypertension</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217686s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>527</th>\n",
       "      <td>2024</td>\n",
       "      <td>7</td>\n",
       "      <td>Duvyzat</td>\n",
       "      <td>givinostat</td>\n",
       "      <td>2024-03-21</td>\n",
       "      <td>To treat Duchenne muscular dystrophy in individuals aged 6 years and olderPress Release</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217865Orig1s000lbl.pdf</td>\n",
       "      <td>https://www.fda.gov/news-events/press-announcements/fda-approves-nonsteroidal-treatment-duchenne-muscular-dystrophy</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>528</th>\n",
       "      <td>2024</td>\n",
       "      <td>8</td>\n",
       "      <td>Winrevair</td>\n",
       "      <td>sotatercept-csrk</td>\n",
       "      <td>2024-03-26</td>\n",
       "      <td>To treat pulmonary arterial hypertension</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761363s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>529</th>\n",
       "      <td>2024</td>\n",
       "      <td>9</td>\n",
       "      <td>Vafseo</td>\n",
       "      <td>vadadustat</td>\n",
       "      <td>2024-03-27</td>\n",
       "      <td>To treat anemia due to chronic kidney disease</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215192s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>530</th>\n",
       "      <td>2024</td>\n",
       "      <td>10</td>\n",
       "      <td>Voydeya</td>\n",
       "      <td>danicopan</td>\n",
       "      <td>2024-03-29</td>\n",
       "      <td>To treat extravascular hemolysis with paroxysmal nocturnal hemoglobinuria</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>531</th>\n",
       "      <td>2024</td>\n",
       "      <td>11</td>\n",
       "      <td>Zevtera</td>\n",
       "      <td>ceftobiprole medocaril sodium</td>\n",
       "      <td>2024-04-03</td>\n",
       "      <td>To treat certain bloodstream infections, bacterial skin and associated tissue infections, and community-acquired bacterial pneumoniaPress Release</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218275s000lbl.pdf</td>\n",
       "      <td>https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532</th>\n",
       "      <td>2024</td>\n",
       "      <td>12</td>\n",
       "      <td>Lumisight</td>\n",
       "      <td>pegulicianine</td>\n",
       "      <td>2024-04-17</td>\n",
       "      <td>To use as an optical imaging agent for the detection of cancerous tissue</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214511s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>533</th>\n",
       "      <td>2024</td>\n",
       "      <td>13</td>\n",
       "      <td>Anktiva</td>\n",
       "      <td>nogapendekin alfa inbakicept-pmln</td>\n",
       "      <td>2024-04-22</td>\n",
       "      <td>To treat bladder cancer</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761336s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>534</th>\n",
       "      <td>2024</td>\n",
       "      <td>14</td>\n",
       "      <td>Ojemda</td>\n",
       "      <td>tovorafenib</td>\n",
       "      <td>2024-04-23</td>\n",
       "      <td>To treat relapsed or refractory pediatric low-grade glioma</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218033s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>535</th>\n",
       "      <td>2024</td>\n",
       "      <td>15</td>\n",
       "      <td>Xolremdi</td>\n",
       "      <td>mavorixafor</td>\n",
       "      <td>2024-04-26</td>\n",
       "      <td>To treat WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis)</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218709s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>536</th>\n",
       "      <td>2024</td>\n",
       "      <td>16</td>\n",
       "      <td>Imdelltra</td>\n",
       "      <td>tarlatamab-dlle</td>\n",
       "      <td>2024-05-16</td>\n",
       "      <td>To treat extensive stage small cell lung cancer</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761344s000lbl.pdf</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     year  year_approval_count  drug_name                  active_ingredient  \\\n",
       "517  2023                   52    Ogsiveo                       nirogacestat   \n",
       "518  2023                   53   Fabhalta                          iptacopan   \n",
       "519  2023                   54   Filsuvez                  birch triterpenes   \n",
       "520  2023                   55     Wainua                        eplontersen   \n",
       "521  2024                    1   Zelsuvmi                         berdazimer   \n",
       "522  2024                    2   Exblifep           cefepime, enmetazobactam   \n",
       "523  2024                    3     Letybo           letibotulinumtoxinA-wlbg   \n",
       "524  2024                    4   Tevimbra                  tislelizumab-jsgr   \n",
       "525  2024                    5  Rezdiffra                         resmetirom   \n",
       "526  2024                    6     Tryvio                       aprocitentan   \n",
       "527  2024                    7    Duvyzat                         givinostat   \n",
       "528  2024                    8  Winrevair                   sotatercept-csrk   \n",
       "529  2024                    9     Vafseo                         vadadustat   \n",
       "530  2024                   10    Voydeya                          danicopan   \n",
       "531  2024                   11    Zevtera      ceftobiprole medocaril sodium   \n",
       "532  2024                   12  Lumisight                      pegulicianine   \n",
       "533  2024                   13    Anktiva  nogapendekin alfa inbakicept-pmln   \n",
       "534  2024                   14     Ojemda                        tovorafenib   \n",
       "535  2024                   15   Xolremdi                        mavorixafor   \n",
       "536  2024                   16  Imdelltra                    tarlatamab-dlle   \n",
       "\n",
       "    approval_date  \\\n",
       "517    2023-11-27   \n",
       "518    2023-12-05   \n",
       "519    2023-12-18   \n",
       "520    2023-12-21   \n",
       "521    2024-01-05   \n",
       "522    2024-02-22   \n",
       "523    2024-02-29   \n",
       "524    2024-03-13   \n",
       "525    2024-03-14   \n",
       "526    2024-03-19   \n",
       "527    2024-03-21   \n",
       "528    2024-03-26   \n",
       "529    2024-03-27   \n",
       "530    2024-03-29   \n",
       "531    2024-04-03   \n",
       "532    2024-04-17   \n",
       "533    2024-04-22   \n",
       "534    2024-04-23   \n",
       "535    2024-04-26   \n",
       "536    2024-05-16   \n",
       "\n",
       "                                                                                                                                          approved_use  \\\n",
       "517                                                 To treat adults with progressing desmoid tumors who require systemic treatmentDrug Trials Snapshot   \n",
       "518                                                                                                       To treat paroxysmal nocturnal hemoglobinuria   \n",
       "519                                                To treat wounds associated with dystrophic and junctional epidermolysis bullosaDrug Trials Snapshot   \n",
       "520                                                       To treat polyneuropathy of hereditary transthyretin-mediated amyloidosisDrug Trials Snapshot   \n",
       "521                                                                                                 To treat molluscum contagiosumDrug Trials Snapshot   \n",
       "522                                                                                                      To treat complicated urinary tract infections   \n",
       "523                                                    To temporarily improve the appearance of moderate-to-severe glabellar linesDrug Trials Snapshot   \n",
       "524                                                         To treat unresectable or metastatic esophageal squamous cell carcinomaDrug Trials Snapshot   \n",
       "525                                          To treat noncirrhotic non-alcoholic steatohepatitis with moderate to advanced liver scarringPress Release   \n",
       "526                                                                                                                              To treat hypertension   \n",
       "527                                                            To treat Duchenne muscular dystrophy in individuals aged 6 years and olderPress Release   \n",
       "528                                                                                                           To treat pulmonary arterial hypertension   \n",
       "529                                                                                                      To treat anemia due to chronic kidney disease   \n",
       "530                                                                          To treat extravascular hemolysis with paroxysmal nocturnal hemoglobinuria   \n",
       "531  To treat certain bloodstream infections, bacterial skin and associated tissue infections, and community-acquired bacterial pneumoniaPress Release   \n",
       "532                                                                           To use as an optical imaging agent for the detection of cancerous tissue   \n",
       "533                                                                                                                            To treat bladder cancer   \n",
       "534                                                                                         To treat relapsed or refractory pediatric low-grade glioma   \n",
       "535                                                                To treat WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis)   \n",
       "536                                                                                                    To treat extensive stage small cell lung cancer   \n",
       "\n",
       "                                                                            drug_link  \\\n",
       "517       https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217677s000lbl.pdf   \n",
       "518       https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/218276s000lbl.pdf   \n",
       "519       https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215064s000lbl.pdf   \n",
       "520       https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217388s000lbl.pdf   \n",
       "521       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217424s000lbl.pdf   \n",
       "522       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216165s000lbl.pdf   \n",
       "523       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761225s000lbl.pdf   \n",
       "524  https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761232Orig1s000lbl.pdf   \n",
       "525       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217785s000lbl.pdf   \n",
       "526       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217686s000lbl.pdf   \n",
       "527  https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217865Orig1s000lbl.pdf   \n",
       "528       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761363s000lbl.pdf   \n",
       "529       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215192s000lbl.pdf   \n",
       "530                                                                              None   \n",
       "531       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218275s000lbl.pdf   \n",
       "532       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214511s000lbl.pdf   \n",
       "533       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761336s000lbl.pdf   \n",
       "534       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218033s000lbl.pdf   \n",
       "535       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218709s000lbl.pdf   \n",
       "536       https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761344s000lbl.pdf   \n",
       "\n",
       "                                                                                                                        press_release  \\\n",
       "517                                                                                                                              None   \n",
       "518                                                                                                                              None   \n",
       "519                                                                                                                              None   \n",
       "520                                                                                                                              None   \n",
       "521                                                                                                                              None   \n",
       "522                                                                                                                              None   \n",
       "523                                                                                                                              None   \n",
       "524                                                                                                                              None   \n",
       "525  https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease   \n",
       "526                                                                                                                              None   \n",
       "527               https://www.fda.gov/news-events/press-announcements/fda-approves-nonsteroidal-treatment-duchenne-muscular-dystrophy   \n",
       "528                                                                                                                              None   \n",
       "529                                                                                                                              None   \n",
       "530                                                                                                                              None   \n",
       "531                              https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses   \n",
       "532                                                                                                                              None   \n",
       "533                                                                                                                              None   \n",
       "534                                                                                                                              None   \n",
       "535                                                                                                                              None   \n",
       "536                                                                                                                              None   \n",
       "\n",
       "                                                                      drug_trials_snapshot  \n",
       "517   https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ogsiveo  \n",
       "518                                                                                   None  \n",
       "519  https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-filsuvez  \n",
       "520    https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-wainua  \n",
       "521  https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-zelsuvmi  \n",
       "522                                                                                   None  \n",
       "523    https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-letybo  \n",
       "524  https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-tevimbra  \n",
       "525                                                                                   None  \n",
       "526                                                                                   None  \n",
       "527                                                                                   None  \n",
       "528                                                                                   None  \n",
       "529                                                                                   None  \n",
       "530                                                                                   None  \n",
       "531                                                                                   None  \n",
       "532                                                                                   None  \n",
       "533                                                                                   None  \n",
       "534                                                                                   None  \n",
       "535                                                                                   None  \n",
       "536                                                                                   None  "
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# set max width of columns to 1000\n",
    "pd.set_option('display.max_colwidth', 1000)\n",
    "pd.set_option('display.max_rows', None)\n",
    "df_all.tail(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "***\n",
    "## Plot Yearly Approval Numbers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# plot number of drugs approved each month each year\n",
    "def plot_nce_monthly(df_all):\n",
    "\n",
    "\t# convert approval_date to datetime\n",
    "\tapproval_dates = pd.to_datetime(df_all['approval_date'])\n",
    "\tdf_all['year_month'] = approval_dates.dt.to_period('M')\n",
    "\tdf_all['year_month'] = df_all['year_month'].dt.to_timestamp()\n",
    "\tdf_all['year_month'] = df_all['year_month'].dt.strftime('%Y-%m')\n",
    "\tdf_all['year_month'] = pd.to_datetime(df_all['year_month'])\n",
    "\tdf_all['year_month'] = df_all['year_month'].dt.strftime('%Y-%m')\n",
    "\tdf_all['year_month'] = pd.to_datetime(df_all['year_month'])\n",
    "\tdf_all['count'] = 1\n",
    "\tdf_all_grouped = df_all.groupby(['year_month', 'year']).count().reset_index()\n",
    "\tdf_all_grouped = df_all_grouped[['year_month', 'count']]\n",
    "\t# plot\n",
    "\tf, ax = plt.subplots(1, 1, figsize=(12, 4))\n",
    "\tax.plot(df_all_grouped['year_month'], df_all_grouped['count'], marker='o')\n",
    "\t# show each month-year on x-axis\n",
    "\tax.set_xlabel('Year')\n",
    "\tax.set_ylabel('Number of Drugs Approved')\n",
    "\tax.set_title('Number of Drugs Approved Each Month Each Year')\n",
    "\tax.set_ylim(0, 10)\n",
    "\t# y-axis shows 0-5-10\n",
    "\tax.set_yticks(range(0, 11, 5))\n",
    "\n",
    "def plot_yearly(df_all_grouped):\n",
    "\t# plot the number of drugs approved each year\n",
    "\tf, ax = plt.subplots(1, 1, figsize=(12, 4))\n",
    "\tax.bar(df_all_grouped['year'], df_all_grouped['count'], ec='black', color='skyblue')\n",
    "\t# show each year on x-axis\n",
    "\tax.set_xlabel('Year')\n",
    "\tax.set_ylabel('Number of Drugs Approved')\n",
    "\tax.set_title('Number of Drugs Approved Each Year')\n",
    "\t# show all years\n",
    "\tax.set_xticks(df_all_grouped['year'])\n",
    "\tax.set_ylim(0, 70)\n",
    "\t# y-axis shows 0-50-100\n",
    "\tax.set_yticks(range(0, 80, 10))\n",
    "\tplt.show()\n",
    "\n",
    "def group_by_year(df_all):\n",
    "\tdf_all['approval_date'] = pd.to_datetime(df_all['approval_date'])\n",
    "\tdf_all['year'] = df_all['approval_date'].dt.year\n",
    "\tdf_all['month'] = df_all['approval_date'].dt.month\n",
    "\tdf_all_grouped = df_all.groupby(['year']).count().reset_index()\n",
    "\tdf_all_grouped = df_all_grouped[['year', 'drug_name']]\n",
    "\tdf_all_grouped.columns = ['year', 'count']\n",
    "\treturn df_all_grouped\n",
    "\n",
    "plot_nce_monthly(df_all)\n",
    "\n",
    "df_all_grouped = group_by_year(df_all)\n",
    "plot_yearly(df_all_grouped)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "# write to csv\n",
    "df_all.to_csv('fda_nce.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "gemini",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
